Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1994 Dec 1;180(6):2079–2088. doi: 10.1084/jem.180.6.2079

The structure of an alternate form of complement C3 that displays costimulatory growth factor activity for B lymphocytes

PMCID: PMC2191791  PMID: 7964485

Abstract

In this study, the structure of a novel 1.9-kb transcript coding for complement component 3 (C3) is described. This alternate C3 is identical to the 3' end of the C3 message beginning at position 3300 of the C3 cDNA. Its transcription appears to be driven by an alternate promoter located within intron 8 of the C3 gene. This alternate C3 message contains an open reading frame that may encode a 536-amino acid- long protein identical to the 3' part of the C3 alpha chain. The resulting protein contains the complement receptor CR2 binding site. The suggested 5' end of coding region of the alternate C3 includes information for a potential hydrophobic leader peptide that would allow secretion of the protein. In vitro assays with macrophage-depleted mouse splenic B cells indicate that an activity is secreted from cell lines transfected with the alternate C3 cDNA. Together with Sepharose- bound immunoglobulin M-specific monoclonal antibodies and interleukin 2, it costimulates the proliferation of B cells. Implications for possible in vivo functions are discussed.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990 Jun;9(6):1897–1906. doi: 10.1002/j.1460-2075.1990.tb08316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnum S. R., Amiguet P., Amiguet-Barras F., Fey G., Tack B. F. Complete intron/exon organization of DNA encoding the alpha' chain of human C3. J Biol Chem. 1989 May 25;264(15):8471–8474. [PubMed] [Google Scholar]
  3. Bird P., Lachmann P. J. The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation. Eur J Immunol. 1988 Aug;18(8):1217–1222. doi: 10.1002/eji.1830180811. [DOI] [PubMed] [Google Scholar]
  4. Bohnsack J. F., Cooper N. R. CR2 ligands modulate human B cell activation. J Immunol. 1988 Oct 15;141(8):2569–2576. [PubMed] [Google Scholar]
  5. Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem. 1981;50:349–383. doi: 10.1146/annurev.bi.50.070181.002025. [DOI] [PubMed] [Google Scholar]
  6. Carter R. H., Spycher M. O., Ng Y. C., Hoffman R., Fearon D. T. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol. 1988 Jul 15;141(2):457–463. [PubMed] [Google Scholar]
  7. Cole F. S., Auerbach H. S., Goldberger G., Colten H. R. Tissue-specific pretranslational regulation of complement production in human mononuclear phagocytes. J Immunol. 1985 Apr;134(4):2610–2616. [PubMed] [Google Scholar]
  8. Corbel C., Melchers F. The synergism of accessory cells and of soluble alpha-factors derived from them in the activation of B cells to proliferation. Immunol Rev. 1984 Apr;78:51–74. doi: 10.1111/j.1600-065x.1984.tb00476.x. [DOI] [PubMed] [Google Scholar]
  9. Da Silva F. P., Hoecker G. F., Day N. K., Vienne K., Rubinstein P. Murine complement component 3: genetic variation and linkage to H-2. Proc Natl Acad Sci U S A. 1978 Feb;75(2):963–965. doi: 10.1073/pnas.75.2.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Domdey H., Wiebauer K., Kazmaier M., Müller V., Odink K., Fey G. Characterization of the mRNA and cloned cDNA specifying the third component of mouse complement. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7619–7623. doi: 10.1073/pnas.79.24.7619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Erdei A., Melchers F., Schulz T., Dierich M. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol. 1985 Feb;15(2):184–188. doi: 10.1002/eji.1830150214. [DOI] [PubMed] [Google Scholar]
  12. Fey G. H., Fuller G. M. Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med. 1987 Dec;4(6):323–338. [PubMed] [Google Scholar]
  13. Fey G. H., Lundwall A., Wetsel R. A., Tack B. F., de Bruijn M. H., Domdey H. Nucleotide sequence of complementary DNA and derived amino acid sequence of murine complement protein C3. Philos Trans R Soc Lond B Biol Sci. 1984 Sep 6;306(1129):333–344. doi: 10.1098/rstb.1984.0094. [DOI] [PubMed] [Google Scholar]
  14. Frohman M. A., Dush M. K., Martin G. R. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci U S A. 1988 Dec;85(23):8998–9002. doi: 10.1073/pnas.85.23.8998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251–7255. doi: 10.1073/pnas.84.20.7251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hebell T., Ahearn J. M., Fearon D. T. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science. 1991 Oct 4;254(5028):102–105. doi: 10.1126/science.1718035. [DOI] [PubMed] [Google Scholar]
  17. Jones N. C., Rigby P. W., Ziff E. B. Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev. 1988 Mar;2(3):267–281. doi: 10.1101/gad.2.3.267. [DOI] [PubMed] [Google Scholar]
  18. Kadonaga J. T., Carner K. R., Masiarz F. R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987 Dec 24;51(6):1079–1090. doi: 10.1016/0092-8674(87)90594-0. [DOI] [PubMed] [Google Scholar]
  19. Katz Y., Revel M., Strunk R. C. Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts. Eur J Immunol. 1989 Jun;19(6):983–988. doi: 10.1002/eji.1830190605. [DOI] [PubMed] [Google Scholar]
  20. Katz Y., Strunk R. C. IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts. J Immunol. 1989 Jun 1;142(11):3862–3867. [PubMed] [Google Scholar]
  21. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979 Oct;123(4):1548–1550. [PubMed] [Google Scholar]
  22. Kusano M., Choi N. H., Tomita M., Yamamoto K., Migita S., Sekiya T., Nishimura S. Nucleotide sequence of cDNA and derived amino acid sequence of rabbit complement component C3 alpha-chain. Immunol Invest. 1986 Jun;15(4):365–378. doi: 10.3109/08820138609052955. [DOI] [PubMed] [Google Scholar]
  23. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  24. Lambris J. D., Ganu V. S., Hirani S., Müller-Eberhard H. J. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4235–4239. doi: 10.1073/pnas.82.12.4235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lernhardt W., Corbel C., Wall R., Melchers F. T-cell hybridomas which produce B lymphocyte replication factors only. Nature. 1982 Nov 25;300(5890):355–357. doi: 10.1038/300355a0. [DOI] [PubMed] [Google Scholar]
  26. Lernhardt W., Karasuyama H., Rolink A., Melchers F. Control of the cell cycle of murine B lymphocytes: the nature of alpha- and beta-B-cell growth factors and of B-cell maturation factors. Immunol Rev. 1987 Oct;99:241–262. doi: 10.1111/j.1600-065x.1987.tb01179.x. [DOI] [PubMed] [Google Scholar]
  27. Lernhardt W., Raschke W. C., Melchers F. Alpha-type B cell growth factor and complement component C3: their possible structural relationship. Curr Top Microbiol Immunol. 1986;132:98–104. doi: 10.1007/978-3-642-71562-4_13. [DOI] [PubMed] [Google Scholar]
  28. Liu Y. J., Johnson G. D., Gordon J., MacLennan I. C. Germinal centres in T-cell-dependent antibody responses. Immunol Today. 1992 Jan;13(1):17–21. doi: 10.1016/0167-5699(92)90199-H. [DOI] [PubMed] [Google Scholar]
  29. Matsuda T., Martinelli G. P., Osler A. G. Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide. J Immunol. 1978 Nov;121(5):2048–2051. [PubMed] [Google Scholar]
  30. Melchers F., Erdei A., Schulz T., Dierich M. P. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature. 1985 Sep 19;317(6034):264–267. doi: 10.1038/317264a0. [DOI] [PubMed] [Google Scholar]
  31. Mårtensson I. L., Leanderson T. Transient gene expression in untransformed lymphocytes. Eur J Immunol. 1987 Oct;17(10):1499–1502. doi: 10.1002/eji.1830171017. [DOI] [PubMed] [Google Scholar]
  32. Nichols W. K. LPS stimulation of complement (C3) synthesis by a human monocyte cell line. Complement. 1984;1(2):108–115. doi: 10.1159/000467823. [DOI] [PubMed] [Google Scholar]
  33. O'Neil K. M., Ochs H. D., Heller S. R., Cork L. C., Morris J. M., Winkelstein J. A. Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol. 1988 Mar 15;140(6):1939–1945. [PubMed] [Google Scholar]
  34. Ochs H. D., Wedgwood R. J., Heller S. R., Beatty P. G. Complement, membrane glycoproteins, and complement receptors: their role in regulation of the immune response. Clin Immunol Immunopathol. 1986 Jul;40(1):94–104. doi: 10.1016/0090-1229(86)90072-3. [DOI] [PubMed] [Google Scholar]
  35. Papamichail M., Gutierrez C., Embling P., Johnson P., Holborow E. J., Pepys M. B. Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol. 1975;4(4):343–347. doi: 10.1111/j.1365-3083.1975.tb02635.x. [DOI] [PubMed] [Google Scholar]
  36. Pepys M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974 Jul 1;140(1):126–145. doi: 10.1084/jem.140.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Perlman D., Halvorson H. O. A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides. J Mol Biol. 1983 Jun 25;167(2):391–409. doi: 10.1016/s0022-2836(83)80341-6. [DOI] [PubMed] [Google Scholar]
  38. Pâques E. P. Purification and partial characterization of the third component of the complement system from porcine serum (C3) and of a crystallizable degradation product of the fourth component of the complement system from human serum (C4). Study of the tryptic digestion products of human and porcine C3 and of human C4. Hoppe Seylers Z Physiol Chem. 1980;361(3):445–456. doi: 10.1515/bchm2.1980.361.1.445. [DOI] [PubMed] [Google Scholar]
  39. Strunk R. C., Whitehead A. S., Cole F. S. Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J Clin Invest. 1985 Sep;76(3):985–990. doi: 10.1172/JCI112099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Thyphronitis G., Kinoshita T., Inoue K., Schweinle J. E., Tsokos G. C., Metcalf E. S., Finkelman F. D., Balow J. E. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol. 1991 Jul 1;147(1):224–230. [PubMed] [Google Scholar]
  41. Tsokos G. C., Lambris J. D., Finkelman F. D., Anastassiou E. D., June C. H. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J Immunol. 1990 Mar 1;144(5):1640–1645. [PubMed] [Google Scholar]
  42. Tsokos G. C., Thyphronitis G., Jack R. M., Finkelman F. D. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD. J Immunol. 1988 Aug 15;141(4):1261–1266. [PubMed] [Google Scholar]
  43. Vetvicka V., Reed W., Hoover M. L., Ross G. D. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. J Immunol. 1993 May 1;150(9):4052–4060. [PubMed] [Google Scholar]
  44. Weigert M. G., Cesari I. M., Yonkovich S. J., Cohn M. Variability in the lambda light chain sequences of mouse antibody. Nature. 1970 Dec 12;228(5276):1045–1047. doi: 10.1038/2281045a0. [DOI] [PubMed] [Google Scholar]
  45. Wiebauer K., Domdey H., Diggelmann H., Fey G. Isolation and analysis of genomic DNA clones encoding the third component of mouse complement. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7077–7081. doi: 10.1073/pnas.79.23.7077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wiersma E. J., Kinoshita T., Heyman B. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur J Immunol. 1991 Oct;21(10):2501–2506. doi: 10.1002/eji.1830211029. [DOI] [PubMed] [Google Scholar]
  47. Wilson D. R., Juan T. S., Wilde M. D., Fey G. H., Darlington G. J. A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6. Mol Cell Biol. 1990 Dec;10(12):6181–6191. doi: 10.1128/mcb.10.12.6181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. de Bruijn M. H., Fey G. H. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci U S A. 1985 Feb;82(3):708–712. doi: 10.1073/pnas.82.3.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 1986 Jun 11;14(11):4683–4690. doi: 10.1093/nar/14.11.4683. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES